Unravel Biosciences, Inc.
Platform for repurposing existing drugs against new therapeutic targets using clinical data analysis
- Sector
- Biotech
- Headquarters
- BOSTON, MA
- Founded
- 2021
- Latest Form D
- $4.1M, Aug 2026
- Total capital
- $5.1M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $5.1M
- 3 Form D · last Aug 2026
- 2 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 9 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$4.1M
- Private capital raisedForm D · SEC · 2nd filing$500K
- Private capital raisedForm D · SEC · 1st filing$500K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- Donald IngberDirectorNamed in SEC Form D filings
- Frederic VigneaultExecutive Officer, DirectorNamed in SEC Form D filings
- Lewis GeffenExecutive OfficerNamed in SEC Form D filings
- Richard NovakExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 9- PendingMethods For Preparing High-purity Vorinostat And Precursors ThereofUSPTOApplication 19382407
- PendingMethods For Preparing High-purity Vorinostat And Precursors ThereofUSPTOApplication PCTUS2025054478
- PendingCompounds For Treating Rett Syndrome And Other DisordersUSPTOApplication 19473875
Show all 9 patent records
- Methods For Preparing High-purity Vorinostat And Precursors ThereofMay 7, 2026 · Application 19382407Pending
- Methods For Preparing High-purity Vorinostat And Precursors ThereofApplication PCTUS2025054478Pending
- Compounds For Treating Rett Syndrome And Other DisordersApplication 19473875Pending
- Methods For Preparing High-purity Vorinostat And Precursors ThereofApplication 63717313Pending
- Methods For Treating Diseases Associated With TAF1 Loss Of FunctionApplication PCTUS2024033552Pending
- Compounds For Treating Rett Syndrome And Other DisordersApplication PCTUS2024024186Pending
- Methods For Treating Diseases Associated With TAF1 Loss Of FunctionApplication 63507633Pending
- Compounds For Treating Rett Syndrome And Other DisordersApplication 63458704Pending
- Methods For Treating Diseases Associated With TAF1 Loss Of FunctionApplication 19492227Pending
Related companies, and why
- DeepkinetiX Inc.Similar federal contract value in Biotech · null in contracts
- Tinos Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- Factor Bioscience LLCSimilar federal contract value in Biotech · null in contracts
- Pinpoint Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- AnTolRx, Inc.Similar federal contract value in Biotech · null in contracts
- Nine Square Therapeutics CorpSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .